Omar Alghazo

Peter MacCallum Cancer Centre

Papers

2

Total Citations

86

H-Index

2

About

Omar Alghazo is a urologic oncologist whose research focuses on advancing surgical and therapeutic strategies for prostate and kidney cancers. He is best known for his pivotal work on the LuTectomy trial, a phase 1/2 study investigating the administration of [177Lu]Lu-PSMA-617 prior to radical prostatectomy in men with high-risk localized prostate cancer. This highly cited study (84 citations) represents a groundbreaking step in combining targeted radioligand therapy with surgery, offering new hope for patients with aggressive disease. Alghazo has also made significant contributions to robotic-assisted partial nephrectomy (RAPN), particularly for challenging hilar renal masses. His single-surgeon series of over 300 cases provides valuable insights into surgical techniques and outcomes for centrally located tumors, comparing hilar versus non-hilar resections. Through his work, Alghazo is helping to refine treatment paradigms, pushing the boundaries of what is possible in urologic oncology. His research not only demonstrates technical excellence but also a commitment to improving patient outcomes through innovative, minimally invasive approaches.

Research Focus

Key Achievements

2
H-Index
2
Papers
86
Total Citations
43
Avg Citations/Paper
🏆 Most Cited Paper
Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study
84 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Peter MacCallum Cancer Centre

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago